Director Assay Product Development - NGS-Based Rare Disease Diagnostics
Baylor Genetics, Houston, TX, United States
Director Assay Product Development - NGS-Based Rare Disease Diagnostics
Job Category
:
R&D
Requisition Number
:
DIREC002265
Apply now
Posted : March 16, 2026
Full-Time
On-site
Locations Showing 1 location
Headquarters Baylor Genetics Houston, TX 77021, USA
Description Job Description
We are seeking an experienced Director of Assay Product Development to lead our next-generation sequencing (NGS) assay development initiatives in the fields of rare disease diagnostics. This leader will drive the design, optimization, and launch of innovative NGS-based assays that enable accurate, clinically meaningful detection of genetic disorders across a broad spectrum of rare inherited diseases.
This role includes direct management of an assay development team, providing mentorship, technical leadership, and strategic direction. The Director will collaborate closely with bioinformatics, validation, laboratory operations, and product management teams to ensure seamless integration of assay development with product vision, regulatory expectations, and operational workflows.
Responsibilities:
Lead and manage a team of assay scientists in the development of NGS-based assays for rare disease diagnostics, spanning WGS, multi-omic workflows, and high‑resolution variant detection.
Oversee project planning, resource allocation, and timeline management to ensure on‑time completion of key milestones.
Define assay design strategies (e.g., panel content, chemistry, workflow, performance targets) aligned with intended clinical use, regulatory expectations, and product requirements.
Translate product requirements and clinical claims into executable technical development plans in partnership with Product Management.
Collaborate with Bioinformatics and Automation teams to ensure seamless integration of wet ‑ lab workflows with analysis pipelines and LIMS.
Collaborate with validation, lab operations, and product teams to ensure robust assay design, validation, and transfer to manufacturing.
Drive innovation in assay design, keeping abreast of emerging technologies and regulatory requirements.
Establish and maintain best ‑ in ‑ class assay development processes, documentation standards, and design controls appropriate for clinical diagnostics.
Identify technical risks early and proactively drive mitigation strategies across functions.
Provide technical leadership and strategic direction for product development initiatives.
Communicate progress, challenges, and achievements to executive leadership and cross‑functional stakeholders.
Qualifications:
PhD or equivalent experience in molecular biology, genetics, or a related field.
Minimum of 7 years of experience in NGS assay development, including rare disease, hereditary disease, or clinical sequencing applications, with 3 or more years in a leadership or management capacity.
Deep expertise in NGS wet ‑ lab workflows (e.g., DNA/RNA library prep, target enrichment, sequencing QC, and high‑sensitivity variant detection).
Proven track record developing and launching NGS assays for inherited disorders or other clinically complex genomics applications.
Strong people management skills with experience leading teams in a product development environment.
Demonstrated ability to collaborate effectively with cross‑functional teams.
Excellent organizational, communication, and leadership skills.
Strong understanding of clinical laboratory environments and regulatory expectations (CLIA/CAP; NYS preferred).
EEO Statement: Baylor Genetics is proud to be an equal opportunity employer dedicated to building an inclusive and diverse workforce. We do not discriminate based on race, religion, color, national origin, sex, sexual orientation, age, gender identity, veteran status, disability, genetic information, pregnancy, childbirth, or related medical conditions, or any other status protected under applicable federal, state, or local law.
Note to Recruiters: We value building direct relationships with our candidates and prefer to manage our hiring process internally. While we occasionally partner with select recruitment agencies for specialized roles, we do not accept unsolicited resumes from recruiters or agencies without a written agreement executed by the authorized signatory for Baylor Genetics ("Agreement"). Any resumes submitted to Baylor Genetics in the absence of an Agreement executed by Baylor Genetics' authorized signatory, will be considered the property of Baylor Genetics, and Baylor Genetics will not be obligated to pay any associated recruitment fees.
Equal Opportunity Employer This employer is required to notify all applicants of their rights pursuant to federal employment laws.For further information, please review the Know Your Rights notice from the Department of Labor.
#J-18808-Ljbffr
:
R&D
Requisition Number
:
DIREC002265
Apply now
Posted : March 16, 2026
Full-Time
On-site
Locations Showing 1 location
Headquarters Baylor Genetics Houston, TX 77021, USA
Description Job Description
We are seeking an experienced Director of Assay Product Development to lead our next-generation sequencing (NGS) assay development initiatives in the fields of rare disease diagnostics. This leader will drive the design, optimization, and launch of innovative NGS-based assays that enable accurate, clinically meaningful detection of genetic disorders across a broad spectrum of rare inherited diseases.
This role includes direct management of an assay development team, providing mentorship, technical leadership, and strategic direction. The Director will collaborate closely with bioinformatics, validation, laboratory operations, and product management teams to ensure seamless integration of assay development with product vision, regulatory expectations, and operational workflows.
Responsibilities:
Lead and manage a team of assay scientists in the development of NGS-based assays for rare disease diagnostics, spanning WGS, multi-omic workflows, and high‑resolution variant detection.
Oversee project planning, resource allocation, and timeline management to ensure on‑time completion of key milestones.
Define assay design strategies (e.g., panel content, chemistry, workflow, performance targets) aligned with intended clinical use, regulatory expectations, and product requirements.
Translate product requirements and clinical claims into executable technical development plans in partnership with Product Management.
Collaborate with Bioinformatics and Automation teams to ensure seamless integration of wet ‑ lab workflows with analysis pipelines and LIMS.
Collaborate with validation, lab operations, and product teams to ensure robust assay design, validation, and transfer to manufacturing.
Drive innovation in assay design, keeping abreast of emerging technologies and regulatory requirements.
Establish and maintain best ‑ in ‑ class assay development processes, documentation standards, and design controls appropriate for clinical diagnostics.
Identify technical risks early and proactively drive mitigation strategies across functions.
Provide technical leadership and strategic direction for product development initiatives.
Communicate progress, challenges, and achievements to executive leadership and cross‑functional stakeholders.
Qualifications:
PhD or equivalent experience in molecular biology, genetics, or a related field.
Minimum of 7 years of experience in NGS assay development, including rare disease, hereditary disease, or clinical sequencing applications, with 3 or more years in a leadership or management capacity.
Deep expertise in NGS wet ‑ lab workflows (e.g., DNA/RNA library prep, target enrichment, sequencing QC, and high‑sensitivity variant detection).
Proven track record developing and launching NGS assays for inherited disorders or other clinically complex genomics applications.
Strong people management skills with experience leading teams in a product development environment.
Demonstrated ability to collaborate effectively with cross‑functional teams.
Excellent organizational, communication, and leadership skills.
Strong understanding of clinical laboratory environments and regulatory expectations (CLIA/CAP; NYS preferred).
EEO Statement: Baylor Genetics is proud to be an equal opportunity employer dedicated to building an inclusive and diverse workforce. We do not discriminate based on race, religion, color, national origin, sex, sexual orientation, age, gender identity, veteran status, disability, genetic information, pregnancy, childbirth, or related medical conditions, or any other status protected under applicable federal, state, or local law.
Note to Recruiters: We value building direct relationships with our candidates and prefer to manage our hiring process internally. While we occasionally partner with select recruitment agencies for specialized roles, we do not accept unsolicited resumes from recruiters or agencies without a written agreement executed by the authorized signatory for Baylor Genetics ("Agreement"). Any resumes submitted to Baylor Genetics in the absence of an Agreement executed by Baylor Genetics' authorized signatory, will be considered the property of Baylor Genetics, and Baylor Genetics will not be obligated to pay any associated recruitment fees.
Equal Opportunity Employer This employer is required to notify all applicants of their rights pursuant to federal employment laws.For further information, please review the Know Your Rights notice from the Department of Labor.
#J-18808-Ljbffr